Breast cancer is ordered into 4 major subtypes based on the presence or absence of molecular markers for estrogen receptors (ER) or progesterone receptors (PR) and human epidermal growth factor 2 (ERBB2; formerly HER2). Here, ERBB2 is linked to breast carcinoma.